Langasog, Fe L.

HRN: 18-87-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/08/2026
07/14/2026
IV
2.25gm
Q6
CAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines